Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Victoria, Lindsay W.Whyte, Ellen M.
Butters, Meryl A.
Meyers, Barnett S.
Alexopoulos, George S.
Mulsant, Benoit H.
Rothschild, Anthony J.
Banerjee, Samprit
Flint, Alastair J.
UMass Chan Affiliations
Department of PsychiatryDocument Type
Journal ArticlePublication Date
2017-02-09Keywords
Cognitionaging
psychotic depression
treatment response
Geriatrics
Mental and Social Health
Mental Disorders
Psychiatry
Psychiatry and Psychology
Metadata
Show full item recordAbstract
OBJECTIVE: To characterize cognitive function at baseline and investigate the relationship between change in cognition, depression, and psychosis after treatment among older adults with major depressive disorder with psychotic features. METHODS: This was a secondary analysis of a double-blind, randomized, controlled treatment trial at inpatient and outpatient settings at four academic health centers on "Young Old" (aged 60-71 years, N = 71) and "Older" (aged 72-86 years, N = 71) participants diagnosed with psychotic depression. Olanzapine plus sertraline or olanzapine plus placebo were given until week 12 or termination. RESULTS: At baseline, Young Old and Older participants did not differ on measures of depression severity or global cognition, information processing speed, and executive function. Improvement in depressive and psychotic symptoms from baseline to treatment end was similar in both the Young Old and Older groups. However, improvement in depressive symptoms was significantly associated with improvement in global cognitive function in Young Old participants but not in Older participants. CONCLUSION: Cognitive dysfunction was not a detriment to improvement in symptoms of psychotic major depression in our geriatric patients. Young Old and Older patients improved to a similar degree on measures of depression and delusions from baseline to treatment end. However, improvement in cognition over the course of treatment was more prominent in the Young Old group than in the Older group.Source
Am J Geriatr Psychiatry. 2017 Feb 9. pii: S1064-7481(17)30198-7. 10.1016/j.jagp.2017.02.006. Link to article on publisher's siteDOI
10.1016/j.jagp.2017.02.006Permanent Link to this Item
http://hdl.handle.net/20.500.14038/46220PubMed ID
28285771Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.jagp.2017.02.006